Athos KG
Overview
Athos KG is a German single-family office for the Strüngmann entrepreneurial family that makes long-term, direct investments with a primary focus on the healthcare and life sciences sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Bambusa Therapeutics | Nov 2025 | Series A Extension | Co-investor |
| Bactolife | Jan 2026 | Series B | Co-investor |
| Antheia | Jan 2026 | Series C Extension | Lead |
| KONUX | Jan 2021 | Series C | - |
| AMSilk | Sep 2025 | VC Round | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Athos KG based?
Athos KG is headquartered in Holzkirchen, Germany.
When was Athos KG founded?
Athos KG was founded in 2019.
How many portfolio companies does Athos KG have?
Athos KG has 13 portfolio companies in Caplight's dataset.
What are some companies in Athos KG's portfolio?
Portfolio companies visible on Caplight include Bambusa Therapeutics, Bactolife, Antheia, KONUX, AMSilk.
What was Athos KG's most recent investment shown here?
Athos KG's most recent investment in this portfolio sample was in Antheia in 2026.
What sectors does Athos KG focus on?
Athos KG focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Frontier & Industrial Tech, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech, Consumer & Commerce.
What company stages does Athos KG focus on?
Athos KG typically invests at the Mid stage.
What is Athos KG's AUM?
Athos KG's assets under management are estimated between $13.6B and $31.0B.